Phenytoin is dissolved in propylene glycol and can lead to severe tissue necrosis (purple glove syndrome) if it extravasates
Each year, an estimated 300,000 adults in the United States die of causes related to obesity [2] According to the guidelines of the National Institute of Health (NIH) regarding the treatment of obesity, weight loss drugs approved by the FDA [US Food and Drug Administration] may only be used as part of a comprehensive weight loss program, including dietary therapy and physical activity, for patients with a BMI [body mass index] of 30 with no concomitant obesity-related risk factors or diseases, and for patients with a BMI of 27 with concomitant obesity-related risk factors or diseases[3].The risk factors and diseases considered important enough to warrant pharmacotherapy at a BMI of 27--29.9 are hypertension, dyslipidemia, coronary heart disease (CHD), type 2 diabetes, and sleep apnea [3]
adults with type 2 diabetes and obesity, those who used GLP-1 therapies had lower risks of dementia, stroke, and all-cause mortality compared to patients on other antidiabetic drugs
Our work is guided by The Pemberton Promise: clear communication, compassionate support, and no fee unless we recover compensation for you
15-30-15 fertilizers
